Bicistronic adenovirus-mediated gene transfer of CTLA4Ig gene and CD40Ig gene result in indefinite survival of islet xenograft

被引:10
作者
Jin, YZ [1 ]
Xie, SS [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100083, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.transproceed.2003.10.064
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Blockade of CD40-CD154 costimulatory pathway in mice and primates with anti-CD154 monoclonal antibodies results in prolonged survival of vascularized organs and islet grafts. CD40Ig, a recombinant fusion protein comprised of the extracellular domain of human CD40 molecule in frame fused with the site-mutated human IgG1 Fc region, abrogated the cognate interaction of CD40-CD154 pathway by binding the CD154 molecule. In this study, replication-defective adenovirus containing the CD40Ig gene was prepared by homologous recombination and used to infect freshly isolated islets from LEW rats (RT-1(1)) in vitro using a titered dose. The islet transfectants (500 per recipient) were transplanted under the left kidney capsule of streptozocin-rendered diabetic C57BL/6 mouse recipient (H-2(b)). The mean survival time of AdCD40Ig-transfected islet grafts was significantly prolonged, while mock-infected grafts and AdEGFP-transfected grafts were rejected in normal fashion. Additionally, dose-dependent prolongation of islet graft survival was observed in mice receiving AdCD40Ig-transfected grafts. In conclusion, local production of Cd40Ig via adenoviral-mediated gene transfer induced dose-dependent prolongation of LEW --> Balb-c islet xenografts.
引用
收藏
页码:3165 / 3166
页数:2
相关论文
共 6 条
[1]   Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig [J].
Feng, S ;
Quickel, RR ;
Hollister-Lock, J ;
McLeod, M ;
Bonner-Weir, S ;
Mulligan, RC ;
Weir, GC .
TRANSPLANTATION, 1999, 67 (12) :1607-1613
[2]   A simplified system for generating recombinant adenoviruses [J].
He, TC ;
Zhou, SB ;
da Costa, LT ;
Yu, J ;
Kinzler, KW ;
Vogelstein, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2509-2514
[3]  
Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162
[4]   CTLA4-Ig and anti-CD4O ligand prevent renal allograft rejection in primates [J].
Kirk, AD ;
Harlan, DM ;
Armstrong, NN ;
Davis, TA ;
Dong, YC ;
Gray, GS ;
Hong, XN ;
Thomas, D ;
Fechner, JH ;
Knechtle, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8789-8794
[5]  
KIRK AD, 2001, AM J TRANSPLANT, V191, pA223
[6]   Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways [J].
Larsen, CP ;
Elwood, ET ;
Alexander, DZ ;
Ritchie, SC ;
Hendrix, R ;
TuckerBurden, C ;
Cho, HR ;
Aruffo, A ;
Hollenbaugh, D ;
Linsley, PS ;
Winn, KJ ;
Pearson, TC .
NATURE, 1996, 381 (6581) :434-438